Search clinical trials for: Vemurafenib
Total 158 results
-
University of ArkansasWithdrawnMultiple MyelomaUnited States
-
Inova Health Care ServicesGenentech, Inc.Withdrawn
-
Center Eugene MarquisCompletedMalignant MelanomaFrance
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Australia
-
Hoffmann-La RocheTerminatedMalignant MelanomaUnited States, France, Australia, United Kingdom, Italy, Spain, Germany, Israel, Poland, Slovakia
-
Radboud University Medical CenterThe Netherlands Cancer Institute; IsalaRecruitingMelanoma, Malignant, of Soft PartsNetherlands
-
Grupo Español Multidisciplinar de MelanomaRoche Farma, S.A; Pivotal S.L.Completed
-
Shanghai Kechow Pharma, Inc.Not yet recruiting
-
Daiichi Sankyo, Inc.PlexxikonTerminatedV600-mutated BRAF Unresectable Melanoma | V600-mutated BRAF Metastatic Melanoma | Stage III or Stage IV Metastatic Melanoma That Has Not Been Previously Treated With a Selective BRAF InhibitorUnited States, Germany, France
-
Celldex TherapeuticsMemorial Sloan Kettering Cancer CenterCompletedThyroid CancerUnited States
-
M.D. Anderson Cancer CenterGenentech, Inc.Active, not recruiting
-
Mohammed M MilhemGenentech, Inc.TerminatedMelanoma | Metastatic Melanoma | BRAF-mutated Metastatic Melanoma | V600EBRAF-mutated Metastatic MelanomaUnited States
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Australia
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.Terminated
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsBelgium, Spain, Germany, Netherlands, Finland
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsSpain, New Zealand, Hungary, Serbia, Germany, Portugal, Netherlands, Greece, Australia
-
Piramal Enterprises LimitedMelanoma Research Foundation Breakthrough ConsortiumSuspendedAdvanced or Inoperable Malignant Melanoma With BRAF MutationUnited States
-
Hoffmann-La RocheCompletedMultiple Myeloma, NeoplasmsUnited States, China, France, Spain, United Kingdom, Germany
-
Clinigen, Inc.Prometheus LaboratoriesTerminatedMetastatic MelanomaUnited States
-
Paola QueiroloIstituto Nazionale per lo Studio e la Cura dei TumoriCompletedMalignant Melanoma Stage IVItaly
-
PfizerCompletedMelanomaCanada, United States, Spain, Germany, Korea, Republic of, Australia, Czechia, Netherlands, France, Hungary, United Kingdom, Switzerland, Singapore, Russian Federation, Italy, Japan, Israel, Brazil, Sweden, Portugal, Mexico, Greece, Argentin... and more
-
Duke UniversityWithdrawn
-
University of California, San FranciscoNovartisCompletedBRAF Mutant Metastatic MelanomaUnited States
-
Hoffmann-La RocheCompletedMalignant Melanoma, CancerHungary
-
Cascadian Therapeutics Inc.TerminatedAdvanced BRAF-mutant CancersUnited States
-
CytomX TherapeuticsCompletedLymphoma | Solid TumorUnited States, Netherlands, Poland, Spain, Ukraine, United Kingdom
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.CompletedMetastatic Colorectal CancerUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
Scripps HealthRecruiting
-
University of LouisvilleJames Graham Brown Cancer CenterRecruiting
-
Netherlands Working Group on Immunotherapy of OncologyHoffmann-La Roche; Amsterdam UMC, location VUmc; The Netherlands Cancer InstituteTerminated
-
Hoffmann-La RocheCompletedMelanomaUnited States, Korea, Republic of, United Kingdom, Australia, France, Belgium, Italy, Portugal, Spain, Brazil, Canada, Russian Federation, Germany, New Zealand, Israel, Poland, Greece, Austria, Hungary, Netherlands
-
West China HospitalRecruitingBRAF V600E-mutated /MSS Metastatic Colorectal Cancer | Vemurafenib (BRAFi) Plus Cetuximab (EGFRi) Combined With PD-1 Monoclonal AntibodyChina
-
Novartis PharmaceuticalsCompleted
-
National Cancer Institute (NCI)TerminatedUnspecified Adult Solid Tumor, Protocol Specific | Recurrent Melanoma | Stage IV Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC MelanomaUnited States
-
Hoffmann-La RocheCompletedMalignant MelanomaSpain, United States, Canada, Germany, Netherlands, France, Italy, United Kingdom, Israel, Australia
-
Philip FriedlanderGenentech, Inc.TerminatedMelanomaUnited States
-
Hoffmann-La RocheCompletedMalignant MelanomaSouth Africa
-
Genentech, Inc.Terminated
-
Hoffmann-La RocheCompleted
-
SanofiCompletedNeoplasm MalignantCanada, United States
-
University of UtahWithdrawn
-
Shanghai Kechow Pharma, Inc.Recruiting
-
HonorHealth Research InstituteBayer; Genentech, Inc.Active, not recruiting
-
Hoffmann-La RocheCompletedNeoplasmsFrance, Hungary, Spain, Korea, Republic of, United Kingdom, United States, Croatia, Greece, Portugal, Germany, Bosnia and Herzegovina, Belgium, South Africa, Israel, Romania, New Zealand, Italy, Canada, Netherlands, Egypt, Russian... and more
-
Fondazione Melanoma OnlusClinical Research Technology S.r.l.Active, not recruiting
-
Shanghai Kechow Pharma, Inc.Recruiting
-
UNICANCERHoffmann-La Roche; National Cancer Institute, France; Fondation ARCActive, not recruitingSolid Tumors | Hematologic Cancers | Metastatic CancersFrance
-
University Hospital TuebingenTerminatedMetastatic Melanoma (Carrying BRAF V600 Mutation)Germany
-
Anna RaciborskaMaria Sklodowska-Curie National Research Institute of Oncology; Łukasiewicz... and other collaboratorsRecruiting